Arcutis today announced that Arcutis management will participate in the 23rd Annual Needham Virtual Healthcare Conference, taking place April 8-11, 2024. Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
Funding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
CHAPEL HILL, N.C., March 28, 2024 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced full year 2023 financial results, and provided clinical development and business updates. Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024 Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
The Atomic Spectroscopy Market by Application, Type, and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. The market is set to experience significant expansion, fueled by several factors including government-led initiatives, technological innovations, and rising applications across various industries. The market, projected to witness a robust Compound Annual Growth Rate (CAGR) of 7.02% between 2022 and 2027, is estimated to increase by a staggering USD 2,214.33 million during this period. One of the primary drivers fueling market growth is the proactive approach taken by governmental organizations worldwide towards environmental testing and ensuring product safety standards. Furthermore, the proliferation of research activities, clinical trials, and the escalating demand for portable spectroscopy systems are contributing significantly to market expansion. Additionally, the burgeoning utilization of atomic spectroscopic techniques in diagnosing ailments like Alzheimer’s disease and monitoring neural health is further propelling market growth. Technological…
Abstract: Countries fundamentally base macro and micro decision making in the field of health on economic considerations, the budgetary impact of technologies being a major criterion. Nevertheless, the value of the technology of interest and its dimensions are more complex if we seek to take decisions based on the value itself. The use of structured and explicit approaches that require the assessment of multiple criteria that reflect the dimensions of this value may significantly improve the quality of the decision making. Multi-criteria decision analysis (MCDA) is a complementary decision-making tool that is able to systematically incorporate dimensions or domains such as ethical, organisational, legal, environmental and social considerations, as well as costs and benefits of medical interventions, together with the distinct perspectives of the interested parties. The objective of this article is to propose the implementation of analysis of non-core…
Forscher von UVA Health haben eine mögliche Erklärung für einige der verwirrendsten Geheimnisse von COVID-19 und Long-COVID entdeckt. Die überraschenden Ergebnisse könnten zu neuen Behandlungen für die schwierigen akuten Auswirkungen von COVID-19, Long-COVID und möglicherweise anderen Viren führen. Forscher unter der Leitung von Steven L. Zeichner, MD, PhD von UVA, fanden heraus, dass COVID-19 den Körper einiger Menschen dazu veranlassen kann, Antikörper zu produzieren, die wie Enzyme wirken, die der Körper auf natürliche Weise zur Regulierung wichtiger Funktionen – zum Beispiel des Blutdrucks – verwendet. Verwandte Enzyme regulieren auch andere wichtige Körperfunktionen wie Blutgerinnung und Entzündungen. Ärzte können diese „Abzyme“ möglicherweise gezielt bekämpfen, um ihre unerwünschten Wirkungen zu stoppen. Wenn Abzyme mit unerwünschten Aktivitäten auch für einige Merkmale von Long-COVID verantwortlich sind, könnten Ärzte die Abzyme gezielt einsetzen, um die schwierigen und manchmal mysteriösen Symptome von COVID-19 und Long-COVID an…
SAN FRANCISCO, Calif., March 28, 2024 /PRNewswire/ — Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse demographics. „As an organization, we have been committed to diversity in clinical trials since day one,“ said Kyle Burtnett, CEO of Headlands Research. „Our partnership with Pfizer has been a critical component in our continued goal of making clinical research accessible to all.“ Home
In Deutschland erkranken jährlich 7.850 Menschen neu an Krebs, der auf eine Infektion mit humanen Papillomviren (HPV) zurückzuführen ist. Dabei wird eine HPV-Infektion zu Unrecht mit einer reinen „Frauenkrankheit“ assoziiert. Denn auch Männer können sich anstecken, das Virus weitergeben und Symptome entwickeln. Doch die Impfbereitschaft in Deutschland ist niedrig. Dabei ist die Impfung der einzige verlässliche Weg, sich vor einer HPV-Infektion zu schützen. Die Deutsche Krebshilfe und das Deutsche Krebsforschungszentrum (DKFZ) schließen sich daher der Forderung des Vorsitzenden der Ständigen Impfkommission (STIKO) Klaus Überla nach flächendeckenden HPV-Impfprogrammen an deutschen Schulen an. Eine Alternative zur Impfung besteht bisher nicht. Moderne Impfstoffe schützen neben den beiden häufigsten Hochrisiko-HPV-Typen HPV 16 und HPV 18 gegen sieben weitere HPV-Typen. Dabei belegen zwei große Studien aus Schweden und Großbritannien zweifelsfrei den Nutzen dieser Impfung. Beide Studien zeigen unabhängig voneinander, dass das Risiko an Gebärmutterhalskrebs zu…
